Fibromyalgia is known for causing widespread pain, constant fatigue, sleep disturbances, and cognitive difficulties that greatly impact quality of life. Despite advances in the field, many individuals continue to look for complementary strategies to support conventional treatment.
One such approach is the AVACEN Treatment Method (ATM), which works through controlled warming of the microcirculation to help the body regulate processes associated with chronic pain.
In an open-label clinical study with fibromyalgia patients, researchers examined the effects of 4 weeks of AVACEN use.
What did they find?
- Single 10-minute daily sessions already helped reduce widespread pain.
- When the protocol was intensified to two 15-minute sessions per day, symptom improvements became even more pronounced.
- Statistically significant reductions were observed in three well-recognized fibromyalgia diagnostic measures:
-
- Widespread Pain Index (WPI)
-
- Tender Point Count (TPC)
-
- Symptom Severity Scale (SS)
-
- No adverse effects were reported.
Why It Matters
The findings suggest that the AVACEN Treatment Method may positively influence recognized fibromyalgia assessment metrics, including WPI, TPC, and SS. By offering a non-invasive and well-tolerated approach, AVACEN could represent a complementary option for individuals seeking to manage pain and improve daily functioning.
Reference:
Muehlbauer TG, Vieira K, (2017) Effects of a 4-week AVACEN Treatment on Pain Perception in Fibromyalgia: An Open Label Study; Fibrom Open Access 2: 124. Available at: https://www.omicsonline.org/open-access/effects-of-a-4week-avacen-treatment-on-pain-perception-in-fibromyalgia-anopen-label-study.pdf